Breast Cancer and PFAS Exposure

Do I have a breast cancer PFAS claim?

There is no way to answer that from a web page alone, but these are the facts a Pennsylvania breast cancer PFAS claim review actually turns on. If most of them describe your situation, it is worth submitting the intake form.

• A confirmed breast cancer diagnosis, documented by pathology or an oncology record.
• A PFAS exposure source you can point to — a public water system, a private well, AFFF firefighting foam, a military base, an airport, or an industrial workplace.
• Time spent at that location: where you lived, worked, or served, and roughly which years.
• Diagnosis timing that follows the exposure period, which is what links the two in a claim review.
• Any supporting paperwork — water-test results, utility bills, employment records, or military service records tying you to the location.

Representation of accepted cases is typically on a contingency-fee basis — no attorneys’ fees unless a recovery is obtained. Clients may remain responsible for case costs and expenses; the written retainer will set out how costs are handled. No case outcome is guaranteed.

PFAS linkage

• PFAS chemicals can interact with endocrine, immune, and metabolic systems that are relevant to breast cancer research.
• Studies have examined PFAS exposure in relation to breast cancer risk, age at diagnosis, hormone-related pathways, and breast cancer subtypes, with evidence still developing.
• Intake review focuses on exposure duration, diagnosis details, receptor status, family history, and whether exposure occurred during sensitive life stages.

Breast cancer symptoms

• A new breast lump, thickening, or area that feels different
• Change in breast size, shape, skin texture, or nipple appearance
• Nipple discharge, especially if bloody or one-sided
• Breast or nipple pain that persists
• Swollen lymph nodes under the arm or near the collarbone

Diagnosis and medical records

• Diagnostic mammogram, ultrasound, or breast MRI
• Core needle biopsy or surgical biopsy
• Pathology testing for ER, PR, HER2, grade, and tumor type
• Staging scans, genetic testing, or genomic tumor assays when appropriate

Treatment options

• Lumpectomy or mastectomy with lymph-node evaluation
• Radiation therapy after breast-conserving surgery or for selected higher-risk cases
• Chemotherapy, endocrine therapy, HER2-targeted therapy, immunotherapy, or CDK4/6 inhibitors depending on subtype
• Reconstruction, survivorship care, and monitoring for recurrence

What patients should gather for intake

• Save biopsy reports, receptor-status results, surgical pathology, oncology notes, and treatment summaries.
• Record family history and any genetic testing, but also document exposure history independently.
• Include residential, occupational, military, airport, firefighting, or industrial exposure details.